Skip Navigation

Cardiovascular Research 2000 45(2):360-369; doi:10.1016/S0008-6363(99)00365-X
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Javadov, S. A.
Right arrow Articles by Halestrap, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Javadov, S. A.
Right arrow Articles by Halestrap, A. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition

Sabzali A. Javadova, Kelvin H.H. Limb, Paul M. Kerrc, M.-Saadah Suleimanb, Gianni D. Angelinib and Andrew P. Halestrapd,*

aAzerbaijan Medical University, Bakykhanov Str., Baku, Azerbaijan
bBristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, UK
cDepartment of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada
dDepartment of Biochemistry, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK

* Corresponding author. Tel.: +44-117-928-8592; fax: +44-117-928-8274 a.halestrap{at}bristol.ac.uk

Objective: Diminishing oxidative stress may protect the heart against ischaemia–reperfusion injury by preventing opening of the mitochondrial permeability transition (MPT) pore. The general anaesthetic agent propofol, a free radical scavenger, has been investigated for its effect on the MPT and its cardioprotective action following global and cardioplegic ischaemic arrest. Method: Isolated perfused Wistar rat hearts were subjected to either warm global ischaemia (Langendorff) or cold St. Thomas’ cardioplegia (working heart mode) in the presence or absence of propofol. MPT pore opening was determined using [3H]-2-deoxyglucose-6-phosphate ([3H]-DOG-6P) entrapment. The respiratory function of isolated mitochondria was also determined for evidence of oxidative stress. Results: Propofol (2 µg/ml) significantly improved the functional recovery of Langendorff hearts on reperfusion (left ventricular developed pressure from 28.4±6.2 to 53.3±7.3 mmHg and left ventricular end diastolic pressure from 52.9±4.3 to 37.5±3.9 mmHg). Recovery was also improved in propofol (4 µg/ml) treated working hearts following cold cardioplegic arrest. External cardiac work on reperfusion improved from 0.42±0.05 to 0.60±0.03 J/s, representing 45–64% of baseline values, when compared to controls (P<0.05). Propofol inhibited MPT pore opening during reperfusion, [3H]-DOG-6P entrapment being 16.7 vs. 22.5 ratio units in controls (P<0.05). Mitochondria isolated from non-ischaemic, propofol-treated hearts exhibited increased respiratory chain activity and were less sensitive to calcium-induced MPT pore opening. Conclusion: Propofol confers significant protection against global normothermic ischaemia and during cold cardioplegic arrest. This effect is associated with less opening of mitochondrial MPT pores, probably as a result of diminished oxidative stress. Propofol may be a useful adjunct to cardioplegic solutions in heart surgery.

KEYWORDS AF, aortic flow-rate; AP, peak aortic pressure; CF, coronary flow-rate; CO, cardiac output; DOG, 2-deoxyglucose; DOG-6P, 2-deoxyglucose-6-phosphate; ECW, external cardiac work; EGTA, ethylene glycol-bis-(2-aminoethyl)-N,N,N',N'-tetraacetic acid; HR, heart rate; KHS, Krebs–Henseleit solution; LAP, left ‘atrial’ pressure; LVDP, left ventricular developed pressure; LVEDP, left ventricular end diastolic pressure; MPT, mitochondrial permeability transition; NTA, nitrilotriacetic acid; TMPD, N,N,N',N'-tetramethyl-p-phenylendiamine; RPP, rate-pressure product


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Ananthakrishnan, M. Kaneko, Y. C. Hwang, N. Quadri, T. Gomez, Q. Li, C. Caspersen, and R. Ramasamy
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore
Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H333 - H341.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Ruiz-Meana, P. Pina, D. Garcia-Dorado, A. Rodriguez-Sinovas, I. Barba, E. Miro-Casas, M. Mirabet, and J. Soler-Soler
Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition
J. Physiol., August 1, 2004; 558(3): 873 - 882.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. King, H. Lin, J. D. McGivan, and M.-S. Suleiman
Aspartate transporter expression and activity in hypertrophic rat heart and ischaemia-reperfusion injury
J. Physiol., May 1, 2004; 556(3): 849 - 858.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. H H Lim, S. A Javadov, M. Das, S. J Clarke, M-S. Suleiman, and A. P Halestrap
The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration
J. Physiol., December 15, 2002; 545(3): 961 - 974.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.